Pfizer’s outlook disappoints after Viagra loses patent protection and Lyrica faces same fate - Earth News Report
Pharmaceutical giant Pfizer reported fourth-quarter earnings and revenue on Tuesday that beat Wall Street's expectations but its guidance for 2019 disappointed investors. Shares of Pfizer fell more than 3 percent in premarket trading. Here's how the company did compared with what Wall Street expected:
